David Kupfer is Director at Minerva Neurosciences, Inc. (NERV). They have made 6 open-market trades across 1 company since 2016, most recently 2021-12-01.
CIK 0001598646
5 open-market purchases totalling $3.6M since 2016, against 1 sale. Across 5 scored buys the stock is up 39.8% at ninety days, and 37.7 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NERV | 163,553 | $383K |
Shares reported on the most recent Form 4, priced at the 2021-12-03 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 100% |
| Avg Move | +1.5% | +2.5% | +39.8% |
| Alpha | +0.6% | -0.8% | +37.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NERV | SELL | 2021-12-01 | 2021-12-03 | $0.88 | $49K | -5.2% | +0.5% | -25.7% |
| NERV | BUY | 2019-06-26 | 2019-06-27 | $5.55 | $56K | +19.7% | +15.1% | +49.4% |
| NERV | BUY | 2016-06-21 | 2016-06-21 | $10.73 | $300K | -5.9% | -4.0% | +24.9% |
| NERV | BUY | 2016-06-20 | 2016-06-21 | $10.80 | $903K | -5.9% | -4.0% | +24.9% |
| NERV | BUY | 2016-06-20 | 2016-06-21 | $10.95 | $303K | -5.9% | -4.0% | +24.9% |
| NERV | BUY | 2016-03-17 | 2016-03-18 | $5.51 | $2.0M | +5.3% | +9.4% | +75.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.